Modelling survival data from hepatorenal syndrome acute kidney injury
Visualitza/Obre
Estadístiques de LA Referencia / Recolecta
Inclou dades d'ús des de 2022
Cita com:
hdl:2117/364893
Tipus de documentProjecte Final de Màster Oficial
Data2022-01
Condicions d'accésAccés obert
Tots els drets reservats. Aquesta obra està protegida pels drets de propietat intel·lectual i
industrial corresponents. Sense perjudici de les exempcions legals existents, queda prohibida la seva
reproducció, distribució, comunicació pública o transformació sense l'autorització del titular dels drets
Abstract
Hepatorenal syndrome (HRS) is a common complication of advanced cirrhosis. It is characterised by renal failure and major disturbances in circulatory function and it is caused by intense vasoconstriction of the renal circulation. Liver transplantation is the treatment of choice for HRS. However, it is not always possible owing to the short survival expectancy. Also, in the last years it has also been proved that the syndrome can be reversed by the simultaneous administration of albumin and arterial vasoconstrictors such as terlipressin. The main aim of this study is to assess the survival of HRS patients that are being treated with albumin, vasopressors or both of them and check whether their response to those treatments is determinant for their survival. To do so, classical competing risks analysis will be performed but also, some other techniques, such as the inclusion of time-varying covariates and the use of landmarking and multi-state models will be introduced. Finally, the results obtained with all the different methods will be compared and discussed.
Fitxers | Descripció | Mida | Format | Visualitza |
---|---|---|---|---|
memoria.pdf | 2,324Mb | Visualitza/Obre |